Not Yet Recruiting
Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Study of Ravulizumab in Chinese Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD)
NCT07557420
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +11 more
- Locations
-
- Research Site Chengdu, China
- Research Site Dongguan, China
- Research Site Shanghai, China
- Research Site Wenzhou, China